Corvus Pharmaceuticals

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer.

Industries

Stage

Post IPO Equity

Employees

51-200

Links

Org chart

Richard A. Miller, M.D.
Co-Founder, CEO & President
Collapse
Erik Verner
Co-Founder & SVP, Research, Angel Pharmaceuticals
Leiv Lea
Chief Financial Officer
William Ben Jones
Senior Vice President, Pharmaceutical Development
James Rosenbaum
SVP, Research
Suresh Mahabhashyam
VP, Clinical Development
Gabriel Luciano
VP, Clinical Operations